aid: bright-peak-therapeutics
name: Bright Peak Therapeutics
description: 'Bright Peak Therapeutics AG is a clinical-stage biotechnology company
  founded in 2018 and co-located in Allschwil, Switzerland (Switzerland Innovation
  Park Basel Area) and San Diego / Del Mar, California. The company engineers next-generation
  multi-functional immunotherapies for cancer and autoimmune disease, using a protein-engineering
  and site-specific chemical-conjugation platform to build multi-functional PD-1 inhibitors
  and cytokine immunoconjugates that combine novel and clinically validated mechanisms
  in a single molecule. Its lead program, BPT567, is a first-in-class PD1-IL18 immunoconjugate
  that entered a Phase 1/2a clinical trial. The company has raised a USD 90 million
  Series C led by Johnson & Johnson Innovation (JJDC) alongside Versant Ventures,
  RA Capital Management, Fidelity, Qatar Investment Authority, Invus, Venrock, KB Investment,
  Alexandria Venture Investments and Northleaf Capital Partners. Bright Peak is a therapeutics
  developer, not a software company: it publishes a corporate marketing site and no
  public developer program, API, SDK or machine-readable specification.'
image: https://brightpeaktx.com/wp-content/uploads/2021/03/brightpeak-logo.png
url: https://raw.githubusercontent.com/api-evangelist/bright-peak-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Biotechnology
- Therapeutics
- Immunotherapy
- Oncology
- Life Sciences
- Pharmaceuticals
- Switzerland
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://brightpeaktx.com/
- type: About
  url: https://brightpeaktx.com/about/
- type: Contact
  url: https://brightpeaktx.com/contact/
- type: PrivacyPolicy
  url: https://brightpeaktx.com/privacy-policy/
- type: TermsOfService
  url: https://brightpeaktx.com/terms-of-service/
- type: LinkedIn
  url: https://www.linkedin.com/company/bright-peak-therapeutics
- type: SecondaryMarket
  url: https://www.hiive.com/securities/bright-peak-therapeutics-stock
- type: DomainSecurity
  url: security/bright-peak-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/bright-peak-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-08'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Bright Peak Therapeutics is a clinical-stage biopharma whose product is a
    PD1-IL18 immunoconjugate, not software; brightpeaktx.com is a five-page WordPress
    marketing site (home, about, contact, privacy, terms) with no developer, docs,
    or API path at all.
  evidence:
  - url: https://brightpeaktx.com/openapi.json
    status: 404
  - url: https://brightpeaktx.com/llms.txt
    status: 404
  - url: https://brightpeaktx.com/.well-known/agent-card.json
    status: 404
  - url: https://brightpeaktx.com/developers
    status: 404
  - url: https://brightpeaktx.com/page-sitemap.xml
    status: 200
  checked: '2026-08-08'